The 10 analysts offering 12-month price forecasts for Immunomedics Inc have a median target of 27.00, with a high estimate of 40.00 and a low estimate of 16.00. The median estimate represents a +28.57% increase from the last price of 21.00.
The current consensus among 10 polled investment analysts is to Buy stock in Immunomedics Inc. This rating has held steady since October, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.47
Reporting Date Feb 26
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.